Genome-wide Loss of Heterozygosity Analysis from Laser Capture Microdissected Prostate Cancer Using Single Nucleotide Polymorphic Allele (SNP) Arrays and a Novel Bioinformatics Platform dChipSNP1,2

Marshall E. Lieberfarb,Ming Lin,Mirna Lechpammer,Cheng Li,David M. Tanenbaum,Phillip G. Febbo,Renee L. Wright,Judy Shim,Philip W. Kantoff,Massimo Loda,Matthew Meyerson,William R. Sellers

IF: 11.2

2003-01-01

Cancer Research

Abstract:Oligonucleotide arrays that detect single nucleotide polymorphisms were used to generate genome-wide loss of heterozygosity (LOH) maps from laser capture microdissected paraffin-embedded samples using as little as 5 ng of DNA. The allele detection rate from such samples was comparable with that obtained with standard amounts of DNA prepared from frozen tissues. A novel informatics platform, dChipSNP, was used to automate the definition of statistically valid regions of LOH, assign LOH genotypes to prostate cancer samples, and organize by hierarchical clus- tering prostate cancers based on the pattern of LOH. This organizational strategy revealed apparently distinct genetic subsets of prostate cancer. and the detection using LOH5 analysis as being essential to the discovery of the genes targeted by such events (2). Oligonucleotide microarrays, capable of simultaneously determining the genotype of 1494 SNPs, have been used to map regions of LOH in small cell lung, breast, bladder, and prostate cancer (3-7). In small cell lung cancer, detection of regions of LOH using SNP arrays was shown to be comparable with LOH detection using microsatellite markers but required cancer cell purity of 90% (3). Similarly, LOH events detected by SNP arrays in bladder cancer were consistent with mic- rosatellite-detected events (6). Here, we show that using this technol- ogy, the genotype of 1494 SNP alleles and genome-wide SNP-based LOH maps can be obtained from laser capture microdissected samples using as little as 5 ng of DNA obtained from paraffin-embedded prostate cancer samples. Furthermore, we demonstrate the utility of a new bioinformatic tool, dChipSNP, that automates the detection of shared regions of LOH, allows for the hierarchical clustering of cancers based on patterns of shared LOH, and allows the analysis of the relationship between clinical parameters and LOH genotypes. Using these methods, we show that subtypes of prostate cancer likely arise through independent genetic pathways.